1. Home
  2. PRPO vs CMND Comparison

PRPO vs CMND Comparison

Compare PRPO & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$28.19

Market Cap

44.4M

Sector

Industrials

ML Signal

N/A

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$0.68

Market Cap

1.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPO
CMND
Founded
N/A
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.4M
1.4M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
PRPO
CMND
Price
$28.19
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.5K
94.1K
Earning Date
04-02-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
35.03
N/A
EPS
N/A
N/A
Revenue
$18,532,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.95
N/A
52 Week Low
$4.90
$0.07
52 Week High
$29.53
$3.25

Technical Indicators

Market Signals
Indicator
PRPO
CMND
Relative Strength Index (RSI) 63.28 25.59
Support Level $22.58 $0.08
Resistance Level N/A $1.10
Average True Range (ATR) 1.45 0.12
MACD 0.32 -0.01
Stochastic Oscillator 92.01 8.64

Price Performance

Historical Comparison
PRPO
CMND

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: